Photo-crosslinked hyaluronic acid nanoparticles with improved stability for invivo tumor-targeted drug delivery

Hong Yeol Yoon, Heebeom Koo, Ki Young Choi, Ick Chan Kwon, Kuiwon Choi, Jae Hyung Park, Kwang Meyung Kim

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

One of the major hurdles of the nanoparticles as drug carriers is the unintended burst release of loaded drugs during blood circulation. To surmount this issue, we developed photo-crosslinked hyaluronic acid nanoparticles (c-HANPs) with improved stability for tumor-targeted drug delivery. They were readily prepared via UV-triggered chemical crosslinking with the acrylate groups in the polymer backbone. The size of c-HANPs was not much different from that of uncrosslinked HANPs. However, c-HANPs exhibited significantly high stability in a physiological buffer and released the loaded drug, paclitaxel (PTX), in a sustained manner. It is noteworthy that the drug release rate from c-HANPs remarkably increased in the presence of hyaluronidase, an enzyme abundant at the intracellular compartments of the tumor cells. It was found from invitro cellular uptake tests that c-HANPs were rapidly taken up by the tumor cells via the receptor (CD44)-mediated endocytosis, which was not inhibited by photo-crosslinking. In non-invasive animal imaging results, they showed higher tumor-targeting ability than uncrosslinked HANPs because high stability of c-HANPs enabled their long circulation in the body. Owing to the sustained release of the drug and enhanced tumor-targeting ability, c-HANPs showed higher therapeutic efficacy compared to free PTX and uncrosslinked HANPs. These data implied the promising potential of c-HANP as tumor-targeting drug carriers and demonstrated the remarkable effect of the improved stability upon the biodistribution and therapeutic efficacy of drug-loaded nanoparticles.

Original languageEnglish
Pages (from-to)5273-5280
Number of pages8
JournalBiomaterials
Volume34
Issue number21
DOIs
Publication statusPublished - 2013 Jul 1

Fingerprint

Hyaluronic acid
Hyaluronic Acid
Nanoparticles
Tumors
Pharmaceutical Preparations
Neoplasms
Drug Carriers
Paclitaxel
Crosslinking
Cells
Targeted drug delivery
Hyaluronoglucosaminidase
Blood Circulation
Hemodynamics
Endocytosis
Buffers
Polymers
Animals
Enzymes
Imaging techniques

Keywords

  • Crosslinking
  • Drug delivery
  • Hyaluronic acid
  • Polymeric nanoparticle
  • Stability

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Photo-crosslinked hyaluronic acid nanoparticles with improved stability for invivo tumor-targeted drug delivery. / Yoon, Hong Yeol; Koo, Heebeom; Choi, Ki Young; Kwon, Ick Chan; Choi, Kuiwon; Park, Jae Hyung; Kim, Kwang Meyung.

In: Biomaterials, Vol. 34, No. 21, 01.07.2013, p. 5273-5280.

Research output: Contribution to journalArticle

Yoon, Hong Yeol ; Koo, Heebeom ; Choi, Ki Young ; Kwon, Ick Chan ; Choi, Kuiwon ; Park, Jae Hyung ; Kim, Kwang Meyung. / Photo-crosslinked hyaluronic acid nanoparticles with improved stability for invivo tumor-targeted drug delivery. In: Biomaterials. 2013 ; Vol. 34, No. 21. pp. 5273-5280.
@article{d014c624ab4e4b9f9e6392483c30dcb8,
title = "Photo-crosslinked hyaluronic acid nanoparticles with improved stability for invivo tumor-targeted drug delivery",
abstract = "One of the major hurdles of the nanoparticles as drug carriers is the unintended burst release of loaded drugs during blood circulation. To surmount this issue, we developed photo-crosslinked hyaluronic acid nanoparticles (c-HANPs) with improved stability for tumor-targeted drug delivery. They were readily prepared via UV-triggered chemical crosslinking with the acrylate groups in the polymer backbone. The size of c-HANPs was not much different from that of uncrosslinked HANPs. However, c-HANPs exhibited significantly high stability in a physiological buffer and released the loaded drug, paclitaxel (PTX), in a sustained manner. It is noteworthy that the drug release rate from c-HANPs remarkably increased in the presence of hyaluronidase, an enzyme abundant at the intracellular compartments of the tumor cells. It was found from invitro cellular uptake tests that c-HANPs were rapidly taken up by the tumor cells via the receptor (CD44)-mediated endocytosis, which was not inhibited by photo-crosslinking. In non-invasive animal imaging results, they showed higher tumor-targeting ability than uncrosslinked HANPs because high stability of c-HANPs enabled their long circulation in the body. Owing to the sustained release of the drug and enhanced tumor-targeting ability, c-HANPs showed higher therapeutic efficacy compared to free PTX and uncrosslinked HANPs. These data implied the promising potential of c-HANP as tumor-targeting drug carriers and demonstrated the remarkable effect of the improved stability upon the biodistribution and therapeutic efficacy of drug-loaded nanoparticles.",
keywords = "Crosslinking, Drug delivery, Hyaluronic acid, Polymeric nanoparticle, Stability",
author = "Yoon, {Hong Yeol} and Heebeom Koo and Choi, {Ki Young} and Kwon, {Ick Chan} and Kuiwon Choi and Park, {Jae Hyung} and Kim, {Kwang Meyung}",
year = "2013",
month = "7",
day = "1",
doi = "10.1016/j.biomaterials.2013.03.050",
language = "English",
volume = "34",
pages = "5273--5280",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "21",

}

TY - JOUR

T1 - Photo-crosslinked hyaluronic acid nanoparticles with improved stability for invivo tumor-targeted drug delivery

AU - Yoon, Hong Yeol

AU - Koo, Heebeom

AU - Choi, Ki Young

AU - Kwon, Ick Chan

AU - Choi, Kuiwon

AU - Park, Jae Hyung

AU - Kim, Kwang Meyung

PY - 2013/7/1

Y1 - 2013/7/1

N2 - One of the major hurdles of the nanoparticles as drug carriers is the unintended burst release of loaded drugs during blood circulation. To surmount this issue, we developed photo-crosslinked hyaluronic acid nanoparticles (c-HANPs) with improved stability for tumor-targeted drug delivery. They were readily prepared via UV-triggered chemical crosslinking with the acrylate groups in the polymer backbone. The size of c-HANPs was not much different from that of uncrosslinked HANPs. However, c-HANPs exhibited significantly high stability in a physiological buffer and released the loaded drug, paclitaxel (PTX), in a sustained manner. It is noteworthy that the drug release rate from c-HANPs remarkably increased in the presence of hyaluronidase, an enzyme abundant at the intracellular compartments of the tumor cells. It was found from invitro cellular uptake tests that c-HANPs were rapidly taken up by the tumor cells via the receptor (CD44)-mediated endocytosis, which was not inhibited by photo-crosslinking. In non-invasive animal imaging results, they showed higher tumor-targeting ability than uncrosslinked HANPs because high stability of c-HANPs enabled their long circulation in the body. Owing to the sustained release of the drug and enhanced tumor-targeting ability, c-HANPs showed higher therapeutic efficacy compared to free PTX and uncrosslinked HANPs. These data implied the promising potential of c-HANP as tumor-targeting drug carriers and demonstrated the remarkable effect of the improved stability upon the biodistribution and therapeutic efficacy of drug-loaded nanoparticles.

AB - One of the major hurdles of the nanoparticles as drug carriers is the unintended burst release of loaded drugs during blood circulation. To surmount this issue, we developed photo-crosslinked hyaluronic acid nanoparticles (c-HANPs) with improved stability for tumor-targeted drug delivery. They were readily prepared via UV-triggered chemical crosslinking with the acrylate groups in the polymer backbone. The size of c-HANPs was not much different from that of uncrosslinked HANPs. However, c-HANPs exhibited significantly high stability in a physiological buffer and released the loaded drug, paclitaxel (PTX), in a sustained manner. It is noteworthy that the drug release rate from c-HANPs remarkably increased in the presence of hyaluronidase, an enzyme abundant at the intracellular compartments of the tumor cells. It was found from invitro cellular uptake tests that c-HANPs were rapidly taken up by the tumor cells via the receptor (CD44)-mediated endocytosis, which was not inhibited by photo-crosslinking. In non-invasive animal imaging results, they showed higher tumor-targeting ability than uncrosslinked HANPs because high stability of c-HANPs enabled their long circulation in the body. Owing to the sustained release of the drug and enhanced tumor-targeting ability, c-HANPs showed higher therapeutic efficacy compared to free PTX and uncrosslinked HANPs. These data implied the promising potential of c-HANP as tumor-targeting drug carriers and demonstrated the remarkable effect of the improved stability upon the biodistribution and therapeutic efficacy of drug-loaded nanoparticles.

KW - Crosslinking

KW - Drug delivery

KW - Hyaluronic acid

KW - Polymeric nanoparticle

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=84877064712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877064712&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2013.03.050

DO - 10.1016/j.biomaterials.2013.03.050

M3 - Article

C2 - 23591396

AN - SCOPUS:84877064712

VL - 34

SP - 5273

EP - 5280

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 21

ER -